To assess the effectiveness of GBS immunisation during pregnancy to reduce neonatal/infant mortality and GBS diseases in pregnant women and their infants.
This is a protocol.
Group B streptococcus immunisation during pregnancy for improving outcomes
You may also be interested in:
- Real-time polymerase chain reaction tests versus antenatal culture tests for the screening of maternal group B Streptococcus colonisation in labour
- Antibiotic prophylaxis during the second and third trimester in pregnancy to reduce adverse pregnancy outcomes and morbidity
- Vaginal chlorhexidine during labour for preventing maternal and neonatal infections (excluding group B streptococcal and HIV)
- Haemophilus influenzae type B and viral influenza vaccinations during pregnancy for improving maternal, neonatal and infant health outcomes
- Antibacterial chlorhexidine applied to the vagina during labour to prevent early-onset group B streptococcal infection in the newborn